Inovio Pharmaceuticals Inc. closed 85.15% below its 52-week high of $14.75, which the company reached on April 1st.

Inovio Pharmaceuticals (NASDAQ:INO) just reported results for the fourth quarter of 2023. Inovio Pharmaceuticals reported earnings per share of -$1.10. This was above the analyst estimate for EPS ...

This was the stock's second consecutive day of losses.

Inovio Pharmaceuticals (NASDAQ:INO – Get Free Report)‘s stock had its “market outperform” rating restated by JMP Securities in a report issued on Friday,Benzinga reports. They currently have a $18.00 ...

S hares of Inovio Pharmaceuticals (INO) have gained 57.3% over the past four weeks to close the last trading session at $9.03, but there could still be a solid upside left in the stock if short ...

What Else: Inovio's lead candidate, INO-4800, a DNA-based COVID-19 vaccine ... to purchase a share – or fractional share – of stock, you can also gain access to shares either by buying ...

Inovio Pharmaceuticals Inc INO shares are trading higher by 17.9% ... ‘fractional shares,' which allows you to own portions of stock without buying an entire share. For example, some stock ...

TORONTO, January 09, 2025--Inovalis Real Estate Investment Trust (the "REIT") (TSX: INO.UN) today announced the signing of an exchange contract for the sale of 87.5% of the Arcueil property to two ...

Nasdaq provides an interactive stock information chart to view history. Downloadable stock history data table is also accessible by clicking on Data Table on the navigation tool bar. If you have ...